Mauro Giacca received his Degree in Medicine from the University of Trieste, Italy in 1984 and his PhD in Microbiology and Virology from the University of Genoa, Italy in 1989. He has been D-G of the ICGEB since 2014, Director of the Italian Component of the ICGEB from 2004-2014 and has been Full Professor of Molecular Biology at the Department of Medicine, University of Trieste since 2005. From 2000-2005 he was Associate Professor of Molecular Biology and Founding Director of the Molecular Biology Laboratory of the “Scuola Normale Superiore” in Pisa, Italy.

He has served on the Boards of various scientific organisations in Italy and abroad. His current research interest focuses on the development of novel biotherapeutics for cardiovascular disorders, with particular reference to the identification of growth factors and microRNAs inducing cardiac regeneration after myocardial infarction. He is an expert in the use of adeno-associated virus (AAV) vectors for cardiovascular applications. He also maintains a strong interest in the molecular biology of HIV-1 infection.

His research activity is funded internationally through grants from various public and private bodies, including the European Research Council (ERC) Advanced Investigator Grants.He has published over 350 papers in peer-reviewed, international journals, in addition to reviews in university texts and books. He regularly contributes articles to national newspapers and champions public engagement and outreach to advocate global sustainable development through biotechnology.

During his mandate he has focused on giving the Organisation a firm and transparent managerial structure, expanding interaction in the biotech sector in ICGEB Member States, advancing scientific research of the laboratories in Trieste, New Delhi and Cape Town and contributing to advanced education of young scientists to promote science and technology-intensive solutions to improve the quality of life.

Research Activity

Cardiovascular disorders, cardiac regeneration, adeno-associated virus (AAV), gene therapy, angiogenesis, microRNAs. Molecular biology of HIV-1 infection

Biographical information

Learn more about the Director general career, activities and publications.

Follow the Director-General on Twitter